| 51 | [[4-(1H-1,2,3,4-tetrazol-5-yl)-2-(trifluoromethyl)phenyl]sulfonylamino]methylboronic acid |
COVPDB38 |
 |
1 |
| 52 | [({[4-(1H-tetrazol-5-yl)phenyl]sulfonyl}amino)methyl]boronic acid |
COVPDB34 |
 |
1 |
| 53 | {4‐[(2S)‐2‐{[(1R)‐4‐{[amino(iminio)methyl]amino}‐1‐(dihydroxyboranyl)butyl]carbamoyl}‐2‐(phenylformamido)ethyl]phenyl}methanaminium |
COVPDB301 |
 |
1 |
| 54 | 4-[[(3~{S})-1-oxidanyl-3,4-dihydro-2,1-benzoxaborinin-3-yl]methylamino]benzenecarboximidamide |
COVPDB1064 |
 |
1 |
| 55 | 4,4'-BIPHENYLDIBORONIC ACID |
COVPDB550 |
 |
1 |
| 56 | {4-[(azetidin-1-yl)sulfonyl]phenyl}boronic acid |
COVPDB1004 |
 |
1 |
| 57 | {4-[(carbamimidoylsulfanyl)methyl]phenyl}boronic acid |
COVPDB967 |
 |
1 |
| 58 | 4-CARBOXYPHENYLboronic acid |
COVPDB223 |
 |
1 |
| 59 | 4-(carboxyvin-2-yl)phenylboronic acid |
COVPDB658 |
 |
1 |
| 60 | 4-(dihydroxyboranyl)-2-[[4-(phenylsulfonyl)thiophen-2-yl]sulfonylamino]benzoic acid |
COVPDB621 |
 |
1 |
| 61 | 4-(dihydroxyboranylmethylsulfamoylmethyl)benzoic acid |
COVPDB581 |
 |
1 |
| 62 | 4-(Ethyl(methyl)carbamoyl)phenyl boronic acid |
COVPDB1409 |
 |
1 |
| 63 | 4-(guanidinomethyl)-phenylboronic acid |
COVPDB899 |
 |
1 |
| 64 | 4-IODO-ACETAMIDO PHENYLBORONIC ACID |
COVPDB936 |
 |
2 |
| 65 | [5-(aminomethyl)-1-benzothiophen-2-yl]boronic acid |
COVPDB898 |
 |
1 |
| 66 | [({[6-(1H-tetrazol-5-yl)pyridin-3-yl]sulfonyl}amino)methyl]boronic acid |
COVPDB35 |
 |
1 |
| 67 | AC-(D)PHE-PRO-BOROARG-OH |
COVPDB710 |
 |
1 |
| 68 | AC-(D)PHE-PRO-BOROHOMOLYS-OH |
COVPDB699 |
 |
1 |
| 69 | AC-(D)PHE-PRO-BOROHOMOORNITHINE-OH |
COVPDB700 |
 |
1 |
| 70 | AC-(D)PHE-PRO-BOROLYS-OH |
COVPDB697 |
 |
1 |
| 71 | AC-(D)PHE-PRO-BORO-N-BUTYL-AMIDINO-GLYCINE-OH |
COVPDB698 |
 |
1 |
| 72 | BENZO[B]THIOPHENE-2-boronic acid |
COVPDB596 |
 |
5 |
| 73 | BOROLOG2 |
COVPDB1330 |
 |
1 |
| 74 | bortezomib |
COVPDB574 |
 |
6 |
| 75 | butylboronic acid |
COVPDB590 |
 |
1 |
| 76 | CB2 |
COVPDB1184 |
 |
1 |
| 77 | (chloromethylsulfonylamino)methylboronic acid |
COVPDB39 |
 |
2 |
| 78 | CR161 |
COVPDB1265 |
 |
1 |
| 79 | Delanzomib |
COVPDB328 |
 |
1 |
| 80 | DIHYDROXY-[[(2-NITROPHENYL)CARBONYLAMINO]METHYL]BORON |
COVPDB1497 |
 |
2 |
| 81 | (D)PHE-PRO-BOROPHE(M-CN) |
COVPDB1235 |
 |
1 |
| 82 | (~{E})-3-[2-(dihydroxyboranyl)phenyl]prop-2-enoic acid |
COVPDB337 |
 |
2 |
| 83 | (~{E})-3-[3-(dihydroxyboranyl)phenyl]prop-2-enoic acid |
COVPDB1040 |
 |
1 |
| 84 | EC04 |
COVPDB455 |
 |
1 |
| 85 | GB0301 |
COVPDB667 |
 |
1 |
| 86 | GSK3448330A |
COVPDB1065 |
 |
1 |
| 87 | Ixazomib |
COVPDB329 |
 |
1 |
| 88 | L-1-NAPHTHYL-2-ACETAMIDO-ETHANE BORONIC ACID |
COVPDB1325 |
 |
1 |
| 89 | LP06 |
COVPDB625 |
 |
9 |
| 90 | L-PARA-CHLORO-1-ACETAMIDO BORONIC ACID |
COVPDB1435 |
 |
1 |
| 91 | M-AMINOPHENYLBORONIC ACID |
COVPDB502 |
 |
3 |
| 92 | ME_096 |
COVPDB1229 |
 |
1 |
| 93 | METHOXYSUCCINYL-ALA-ALA-PRO-ALANINE BORONIC ACID |
COVPDB527 |
 |
5 |
| 94 | METHOXYSUCCINYL-ALA-ALA-PRO-VALINE BORONIC ACID |
COVPDB529 |
 |
4 |
| 95 | MS05 |
COVPDB593 |
 |
1 |
| 96 | N1-[(1R)-1-(DIHYDROXYBORYL)ETHYL]-N2-[(TERT-BUTOXYCARBONYL)-D-GAMMA-GLUTAMYL]-N6-[(BENZYLOXY)CARBONYL-L-LYSINAMIDE |
COVPDB575 |
 |
1 |
| 97 | N-[(1R)-1-borono-3-methylbutyl]-N~2~-(2-chloro-4-methoxybenzene-1-carbonyl)-L-leucinamide |
COVPDB1000 |
 |
1 |
| 98 | N-{2-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]ethyl}guanidine |
COVPDB213 |
 |
1 |
| 99 | N-2-THIOPHEN-2-YL-ACETAMIDE BORONIC ACID |
COVPDB657 |
 |
1 |
| 100 | N-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]guanidine |
COVPDB216 |
 |
1 |